Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Antibe Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

BusinessWire_EN 
0 0 15.09.20
Antibe Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
 

Antibe Therapeutics Inc. (TSXV: ATE, OTCQB: ATBPF), a clinical stage company leveraging its unique hydrogen sulfide platform to develop safer medicines for pain and inflammation, today announced that Dan Legault, Antibe’s Chief Executive Officer, will present a corporate overview at the upcoming virtual Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on Wednesday, September 22, 2020 at 9:10 am (Eastern Time).

A live webcast of the presentation will be available on the Company’s website at www.antibethera.com/events. Following the presentation, a replay of the webcast will be available on the website for 90 days.

About Antibe Therapeutics Inc.
Antibe is leveraging its proprietary hydrogen sulfide platform to develop next-generation, safer nonsteroidal anti-inflammatory drugs (“NSAIDs”) for pain and inflammation arising from a wide range of medical conditions. Antibe is developing three assets that seek to overcome the gastrointestinal (“GI”) ulcers and bleeding associated with NSAIDs. Antibe’s lead drug, otenaproxesul (ATB-346), is entering Phase III for osteoarthritis pain. Additional assets under development include a safer alternative to opioids for peri-operative pain, and a GI-safe alternative to low-dose aspirin. Learn more at antibethera.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200915005318/en/

Antibe Therapeutics Inc. Stock

€0.10
31.580%
A very strong showing by Antibe Therapeutics Inc. today, with an increase of €0.024 (31.580%) compared to yesterday's price.

Show more
Like: 0
Share
BusinessWire_EN 
Business Wire, a Berkshire Hathaway company, is the global leader in press release distribution and regulatory disclosure. Investor relations, public relations, public policy and marketing professionals rely on Business Wire for secure and accurate distribution of market-moving news and multimedia.

Legal notice

Comments

Not a member yet? Sign up for free!